(Q44297038)

English

Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

object named as

Shigeru Kohno

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Hajime Isomoto

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kenichiro Inoue

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Hisashi Furusu

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Hitoshi Nishiyama

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Saburo Shikuwa

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Katsuhisa Omagari

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yohei Mizuta

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kunihiko Murase

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ikuo Murata

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

111-119

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Helicobacter pylori and the pathogenesis of gastroduodenal inflammation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Five minute endoscopic urea breath test with 25 mg of (13)C-urea in the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

The role of antisecretory drugs in the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Review article: the pharmacology of rabeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Resistance of Helicobacter pylori to antibiotics

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Guidelines in the management of Helicobacter pylori infection in Japan

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication—a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00131.X

21 January 2018

Identifiers

10.1046/J.1523-5378.2003.00131.X

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

release_w4lwi2pjlrehvcgvqlzfbv5wru

1 reference

https://api.fatcat.wiki/v0/release/w4lwi2pjlrehvcgvqlzfbv5wru

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44297038&oldid=2109251820"